Reply to: “Statistical pitfalls in interpreting zero HCC risk and HBsAg clearance in the long-term PAGE-B cohort”
- 15 October 2026
- journal article
- Published by Elsevier in Journal of Hepatology
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohortJournal of Hepatology, 2026
- AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert ReviewGastroenterology, 2026
- EASL Clinical Practice Guidelines on the management of hepatitis B virus infectionJournal of Hepatology, 2025
- Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis BJournal of Clinical Investigation, 2022
- Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision MedicineHepatology, 2020
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapyJournal of Hepatology, 2016
- Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA LevelJAMA, 2006